Unichem Laboratories Ltd.

NSE: UNICHEMLAB | BSE: 506690 | ISIN: INE351A01035 | Industry: Pharmaceuticals
| Falling Comet
574.1000 -15.70 (-2.66%)
NSE Jun 18, 2025 15:31 PM
Volume: 46,917
 

574.10
-2.66%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 13% YoY to | 344 crore (I-direct estimate: | 350 crore) on account of 18% growth in export sales to | 119 crore (I-direct estimate: | 125 crore). Domestic sales grew 7% YoY to | 187 crore (Idirect estimate: | 197 crore) EBITDA margins declined 30 bps YoY to 9.8% (I-direct estimate: 12.8%) mainly due to higher employee and other expenditure. EBITDA increased 9% YoY to | 34 crore (I-direct estimate: | 45 crore) Net profit increased 14% YoY to | 32 crore (I-direct estimate of | 34.2)....
Unichem Laboratories Ltd. has lost -26.51% in the last 6 Months
More from Unichem Laboratories Ltd.
Recommended